Literature DB >> 30926016

Imaging for Risk Stratification in Atrial Fibrillation with Heart Failure.

Kennosuke Yamashita1, Ravi Ranjan2.   

Abstract

Atrial fibrillation (AF) is the most common cardiac rhythm disorder and is associated with heart failure (HF). Cardiac imaging modalities play an important role in risk assessment and managing AF. This article reviews the use of cardiac imaging for risk assessment and to optimize treatment strategy in patients with AF and HF. First, the clinical role of echocardiography, computed tomography, and cardiac magnetic resonance for risk stratification is provided. Second, the value of imaging in catheter ablation is reviewed, including preoperative assessment, optimizing patient selection for ablation, use during the ablation procedure, and postoperative scar assessment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cardiac MRI; Computed tomography; Echocardiography; Heart failure

Mesh:

Year:  2019        PMID: 30926016      PMCID: PMC6446587          DOI: 10.1016/j.ccl.2019.01.007

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  51 in total

1.  Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial.

Authors:  Michael R MacDonald; Derek T Connelly; Nathaniel M Hawkins; Tracey Steedman; John Payne; Morag Shaw; Martin Denvir; Sai Bhagra; Sandy Small; William Martin; John J V McMurray; Mark C Petrie
Journal:  Heart       Date:  2010-11-04       Impact factor: 5.994

2.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

3.  Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure.

Authors:  Matteo Bertini; C Jan Willem Borleffs; Victoria Delgado; Arnold C T Ng; Sebastiaan R D Piers; Miriam Shanks; M Louisa Antoni; Mauro Biffi; Giuseppe Boriani; Martin J Schalij; Jeroen J Bax; Nico R L Van de Veire
Journal:  Eur J Heart Fail       Date:  2010-10       Impact factor: 15.534

Review 4.  Atrial fibrosis and the mechanisms of atrial fibrillation.

Authors:  Thomas H Everett; Jeffrey E Olgin
Journal:  Heart Rhythm       Date:  2006-12-28       Impact factor: 6.343

5.  Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique.

Authors:  Feifan Ouyang; Matthias Antz; Sabine Ernst; Hitoshi Hachiya; Hercules Mavrakis; Florian T Deger; Anselm Schaumann; Julian Chun; Peter Falk; Detlef Hennig; Xingpeng Liu; Dietmar Bänsch; Karl-Heinz Kuck
Journal:  Circulation       Date:  2004-12-27       Impact factor: 29.690

6.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

7.  Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation.

Authors:  Felix Gramley; Johann Lorenzen; Jurgita Plisiene; Mindaugas Rakauskas; Rimantas Benetis; Michael Schmid; Rüdiger Autschbach; Christian Knackstedt; Thomas Schimpf; Karl Mischke; Axel Gressner; Peter Hanrath; Malte Kelm; Patrick Schauerte
Journal:  J Cardiovasc Electrophysiol       Date:  2007-07-26

8.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

Authors:  Mohammed N Khan; Pierre Jaïs; Jennifer Cummings; Luigi Di Biase; Prashanthan Sanders; David O Martin; Josef Kautzner; Steven Hao; Sakis Themistoclakis; Raffaele Fanelli; Domenico Potenza; Raimondo Massaro; Oussama Wazni; Robert Schweikert; Walid Saliba; Paul Wang; Amin Al-Ahmad; Salwa Beheiry; Pietro Santarelli; Randall C Starling; Antonio Dello Russo; Gemma Pelargonio; Johannes Brachmann; Volker Schibgilla; Aldo Bonso; Michela Casella; Antonio Raviele; Michel Haïssaguerre; Andrea Natale
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

Review 9.  Atrial fibrillation in heart failure: the chicken or the egg?

Authors:  R Balasubramaniam; P M Kistler
Journal:  Heart       Date:  2008-07-16       Impact factor: 5.994

10.  Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.

Authors:  C Jan Willem Borleffs; Claudia Ypenburg; Rutger J van Bommel; Victoria Delgado; Lieselot van Erven; Martin J Schalij; Jeroen J Bax
Journal:  Heart Rhythm       Date:  2008-12-13       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.